Linking Parkinson's Disease and Melanoma: Interplay Between α‐Synuclein and Pmel17 Amyloid Formation
Parkinson's disease (PD) is a neurodegenerative disorder associated with the death of
dopaminergic neurons within the substantia nigra of the brain. Melanoma is a cancer of …
dopaminergic neurons within the substantia nigra of the brain. Melanoma is a cancer of …
Alpha-synuclein in peripheral tissues as a possible marker for neurological diseases and other medical conditions
FJ Jiménez-Jiménez, H Alonso-Navarro… - Biomolecules, 2023 - mdpi.com
The possible usefulness of alpha-synuclein (aSyn) determinations in peripheral tissues
(blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological …
(blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological …
Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy
G Vivacqua, A Suppa, R Mancinelli, D Belvisi… - Parkinsonism & related …, 2019 - Elsevier
Introduction Alpha-synuclein (α-syn) aggregation is the pathological hallmark of Parkinson's
Disease (PD). In this study, we measured α-syn total (α-syn total), oligomeric α-syn (α-syn …
Disease (PD). In this study, we measured α-syn total (α-syn total), oligomeric α-syn (α-syn …
Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies
E Vacchi, E Lazzarini, S Pinton, G Chiaro, G Disanto… - Brain, 2022 - academic.oup.com
Abnormal accumulation of microtubule-associated protein tau (τ) is a characteristic feature of
atypical parkinsonisms with tauopathies, such as progressive supranuclear palsy and …
atypical parkinsonisms with tauopathies, such as progressive supranuclear palsy and …
Tau and alpha synuclein synergistic effect in neurodegenerative diseases: When the periphery is the core
In neuronal cells, tau is a microtubule-associated protein placed in axons and alpha
synuclein is enriched at presynaptic terminals. They display a propensity to form pathologic …
synuclein is enriched at presynaptic terminals. They display a propensity to form pathologic …
Skin disorders in Parkinson's disease: potential biomarkers and risk factors
AH Ravn, JP Thyssen, A Egeberg - Clinical, cosmetic and …, 2017 - Taylor & Francis
Parkinson's disease (PD) is one of the most common neurodegenerative disorders,
characterized by a symptom triad comprising resting tremor, rigidity, and akinesia. In …
characterized by a symptom triad comprising resting tremor, rigidity, and akinesia. In …
Tau immunoreactivity in peripheral tissues of human aging and select tauopathies
BN Dugger, BR Hoffman, A Scroggins, GE Serrano… - Neuroscience …, 2019 - Elsevier
Many studies have been directed at understanding mechanisms of tau aggregation and
therapeutics, nearly all focusing on the brain. It is critical to understand the presence of tau in …
therapeutics, nearly all focusing on the brain. It is critical to understand the presence of tau in …
Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?
C Painous, M Fernández, J Pérez, L de Mena… - Parkinsonism & Related …, 2024 - Elsevier
Over the last two decades there have been meaningful developments on biomarkers of
neurodegenerative diseases, extensively (but not solely) focusing on their proteinopathic …
neurodegenerative diseases, extensively (but not solely) focusing on their proteinopathic …
Presence of skin α-synuclein deposits discriminates Parkinson's disease from progressive supranuclear palsy and corticobasal syndrome
MP Giannoccaro, P Avoni, G Rizzo… - Journal of …, 2022 - content.iospress.com
Background: Previous studies reported skin phosphorylated α-synuclein (p-syn) deposits in
Parkinson's disease (PD) patients but not in patients with parkinsonism due to tauopathies …
Parkinson's disease (PD) patients but not in patients with parkinsonism due to tauopathies …
Neurodegenerative disease-related proteins within the epidermal layer of the human skin
SC Akerman, S Hossain, A Shobo… - Journal of …, 2019 - journals.sagepub.com
There is increasing evidence suggesting that amyloidogenic proteins might form deposits in
non-neuronal tissues in neurodegenerative disorders such as Alzheimer's or Parkinson's …
non-neuronal tissues in neurodegenerative disorders such as Alzheimer's or Parkinson's …